IDEAYA Biosciences, Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
Strong balance sheet of $393.9 million cash, cash equivalents and marketable securities as of September 30, 2022 is anticipated to fund planned operations into...
Source: prnewswire.com